In a scrutiny of 39 randomly picked drugs in India, a parliamentary panel found that in case of 11 drugs (28%), mandatory phase-III clinical trials were not conducted.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/dgci-approving-one-drug-month-without-clinical-trials-panel-report
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/times-india-new-delhi
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-care
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/india
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/medical-research
[7] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[8] http://admin.indiaenvironmentportal.org.in/category/thesaurus/central-drug-research-institute-cdri